Sakar Healthcare Expands Global Oncology Footprint and Secures Key Regulatory Approvals
Sakar Healthcare Ltd 路 Others (Uncategorized) 路 14 Oct 2026, 7:31 pm
Sakar Healthcare Expands Global Oncology Footprint and Secures Key Regulatory Approvals Sakar Healthcare is accelerating its oncology exports across the EU, UK, APAC, Canada, and LatAm, securing 22 Marketing Authorisations out of 190 submissions globally. The company achieved 11 site-variation approvals with major MNCs and received two CEP approvals out of seven applications for its 21 in-house APIs to support vertical integration. Commercial supplies have commenced from its EU GMP-approved oncology FDF facility. Additionally, management clarified that proposed domestic MRP caps on oncology drugs will not impact operations, as business is export-skewed and trade margin caps leave manufacturer realizations unaffected.
Original exchange filing (PDF)
More announcements from Sakar Healthcare Ltd
- Sakar Healthcare Limited has informed the Exchange about Transcript 路 02 Nov 2026
- Sakar Healthcare Limited has informed the Exchange about Link of Recording 路 27 Oct 2026
- Sakar Healthcare Limited has informed the Exchange about Investor Presentation 路 26 Oct 2026
- Sakar Healthcare Limited has informed the Exchange regarding a press release dated October 26, 2026, titled "Press Release - Consolidated and Standalone Unaudited Financial Results for the quarter and half year ended September 30, 2026". 路 26 Oct 2026
- Sakar Healthcare Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 23 Oct 2026
- Sakar Healthcare Limited has informed the Exchange about Schedule of meet 路 27 Oct 2026
- SAKAR HEALTHCARE LIMITED has informed the Exchange about Board Meeting to be held on 23-Oct-2026 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended September 2026 and Other business. 路 23 Oct 2026
- To consider and approve the financial results for the period ended September 30, 2026 and other business matters 路 23 Oct 2026
